Threshold Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development of tumor-targeted medicines to improve the lives of individuals with cancer.

Latest News

June 13, 2017
Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide and Ipilimumab

March 17, 2017
Threshold Pharmaceuticals and Molecular Templates Agree to Combine

December 19, 2016
Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424

November 15, 2016
Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2016

View all news releases


November 16, 2016
Stifel 2016 Healthcare Conference
New York, NY

View All Events